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AGGRESSIVE INTRACRANIAL FIBROMATOSIS
Case report
Oswaldo Inácio de Tella Jr1, Luciano Ricardo França Silva2, João Norberto Stavale3,
Marco Antonio Herculano4, Manoel Antonio de Paiva Neto5, Celso Agner6
ABSTRACT - Fibromatosis is a locally aggressive, proliferative fibroblastic lesion affecting musculoaponeu-
rotic stru c t u res, most often in the limbs and trunk. Intracranial fibromatosis is extremely rare and re q u i re s
a g g ressive treatment to prevent re c u rrence. Case Description - We present the case of a 20 year old woman
with aggressive skull base fibromatosis. The lesion extended through the sphenoid, ethmoid sinus and
nasal cavity, destroying the right roof of the orbit and penetrating in anterior skull base. A combined ante-
rior craniofacial approach was perf o rmed; complete resection with surgical margin was impossible due to
the localization of the tumor and relation to important neurovascular stru c t u res. Complete resection with
s u rgical margin is often impossible because of its widely infiltrative nature. Radiotherapy and chemother-
apy are often required to improve local control of the lesion.
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Fibromatose agressiva Intracraniana: relato de caso
RESUMO – Fibromatose é lesão fibroblástica proliferativa com agressividade localizada, afetando as estru-
turas músculo-aponeuróticas e acometendo, mais freqüentemente, os membros e tronco. A fibro m a t o s e
intracraniana é rara e requer tratamento agressivo para evitar recidiva. Descrevemos uma paciente de 20
anos portadora de fibromatose agressiva de base de crânio. A lesão se estendia através da cavidade nasal,
seios esfenoidal e etmoidal, destruindo o teto da órbita direita e invadindo a porção anterior da base do
crânio. A paciente foi submetida a uma via craniofacial anterior combinada, não sendo possível uma
ressecção completa devido ao envolvimento de estruturas neuro v a s c u l a res. A ressecção completa é, fre-
qüentemente, impossível devido sua natureza infiltrativa. Radioterapia e quimioterapia são indicadas para
melhorar o controle da lesão.
PALAVRAS-CHAVE: fibromatose intracraniana, base do crânio, via craniofacial.
authors, as the lesions tend to recur after surg i c a l
resection.
The purpose of this re p o rt is to describe a case of
intracranial fibromatosis involving the skull base1,2.
CASE
A 20 years old woman presented with a two years his-
t o ry of right proptosis and nasal obstruction. Physical exam-
ination revealed a rigth proptosis with no neuro l o g i c a l
a b n o rm a l i t y. A computadorized tomograph (CT) scan
revealed a lesion extended through the sphenoid and eth-
moid sinus, into nasal cavity , destroying the right roof of
the orbit and the anterior floor of the cranial base. The
magnetic resonance image (MRI) findings confirmed a larg e
Aggressive fibromatosis are fibrous tissue prolif-
erations that arise from the connective tissue of mus-
cle and its overlying fascia. They tend to infiltrate
s u rrounding tissues, making complete surgical re s e c-
tion difficult. The nomenclature that has been used
in the literature to describe this lesion is confusing.
The characteristics fall between fibromas and low
grade fibro s a rcomas. Unlike fibro s a rcomas, fibro-
matoses are without metastatic potential but tend
to behave locally in an aggressive and infiltrative
m a n n e r, making complete surgical resection diff i c u l t .
The terms “desmoid tumor” or “aggressive fibro m a-
tosis” are used as synonyms for fibromatosis by some
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cranial base lesion which enhanced homogeneously after
contrast (Fig 1).
S u rgical resection was perf o rmed through a combined
f rontal craniotomy and an anterior craniofacial appro a c h
( Weber Fergunson incision). A right frontal craniotomy per-
mitted the dissection of the duramater that was not appa-
rently infiltrated by the tumor. Inferiorly a midfacial, trans-
maxillar approach was perf o rmed and a extremely dense fi-
b rous tissue infiltrating through bony stru c t u res was seen,
and a sub total resection of the tumor, and surrounding in-
vaded stru c t u res was achieved. Histopathological examina-
tion showed fibroblastics spindle cells with mild nuclear pleo-
morphism with a generous collagenous component (Fig 2).
The patient had an uneventful postoperative re c o v e ry,
with resolution of proptosis. Post-operative CT showed no
residual tumor. Follow-up MRI, eighth months post-oper-
ative showed re c u rrent tumoral tissue in the skull base cen-
t red upon the basi-sphenoid (Fig 3). The patient was sub-
mitted to a new surgical resection using an endoscopic nasal
approach to the lesion, this time with partial removal.
DISCUSSION
Fibromatosis is a tumour-like fibrolastic prolifer-
ation characterized by a tendency to infiltrate sur-
rounding tissues and to recur locally after surg i c a l
excision, but not associated with a capacity for metas-
t a s i s3 , 4. Fibromatosis can occur at any age, but is more
common between the ages of 20 and 40 years, with
a female predominance in most series. Head and neck
Fig 1. Sagittal and axial pre-operative MRI  showing a large cranial base lesion which enhanced
homogeneously after contrast.
Fig 2. The tumor is composed of interlacing of fibroblasts and varying amounts of collagen.
H.E., 200X.
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fibromatosis tend to display characteristics that dif-
fer somewhat form aggressive fibromatosis in other
locations. They tend to occur in a younger age gro u p ,
often in the first or second decade and have a high
re c u rrence rate1 , 2 , 5. Most cases of aggressive fibro-
matosis are sporadic, but fibromatosis can also occur
in association with familial adenomatous polyposis
as part of Gardner´s syndrome6,7.
The rate of local re c u rrence after surgical re s e c-
tion ranges from 27 to 77%. Most re c u rrences occur
within two years. Death is uncommon but may occur
as a result of compression of vital stru c t u res, such as
the trachea. Approximately 9 to 27% of aggre s s i v e
f i b romatosis are located in the head and neck. Head
and neck fibromatosis may behave somewhat diff e r-
ently from other aggressive fibromatosis2.
The nomenclature that has been used in the lite-
r a t u re to describe fibromatosis is confusing. Synonyms
for aggressive fibromatosis include desmoid tumor,
desmoid fibromatosis, deep fibromatosis, Grade 1 fi-
b ro s a rcoma (desmoid type), desmoma, and desmo-
plastic fibroma of bone5.
F i b romatosis usually present as painless masses,
h o w e v e r, pain is not an unusual symptom. Neuro p a-
thic “shooting” pain occurs rare l y. In the head and
neck area functional deficits, including trismus, speech
impairment, dysphasia, nasal obstruction, and diffi-
culty in closing the eye, have been re p o rt e d7 , 8. It is
often difficult to ascertain the site of origin of an ag-
g ressive fibromatosis, but most authors tend to agre e
that intracranial fibromatosis arises from the dura3 , 4.
In our case due to the diffuse appearence of the tu-
mor, it was impossible to precise the site of origin.
H i s t o l o g i c a l l y, desmoid fibromatosis arising in
adulthood, irrespective of site, is composed of spin-
dle-shaped, uniform cells surrounded by abundant
collagen and arranged in interlacing fascicles or a
pseudolobulated pattern. The degree of cellularity
is usually moderate but can vary from area to are a
within the tumor. Nuclei are never atypical or hyper-
c h romatic, and mitoses can occur but are never ab-
n o rmal. Mononuclear cells, usually mast cells, are
s c a t t e red throughout the stroma. Infiltration into
adjacent stru c t u res occurs fre q u e n t l y, even when the
mass appears grossly well circumscribed. Diff e re n t i a-
ting tumor tissue from peripheral scar can be diff i-
cult. Bony erosions, as ocurred in our case, may occur
when the periosteum is involved. The diff e re n t i a l
diagnosis for pathologist includes fibro s a rcoma, re a c-
tive fibrosis, and nodular fasciitis2,5,9.
Fibromatosis have typical MRI features. They are
isointense to slightly hyperintense in T1 weighted
images, intermediate between muscle and fat in T2
weighted images and enhance after administration
of contrast agent. These typical findings were evi-
dent in our patient. The lack of peritumoral soft tis-
sue oedema and the presence of areas with very low
signal intensity in T2 weighted images suggested a
slowly growing and more benign proliferative soft
tissue disorder10.
The treatment of choice for intracranial fibro m a-
tosis is surg e ry with adjuvant radiotherapy and che-
motherapy being indicated for some authors, al-
though the effects of these therapies is unclear3 , 4. No
clinical trials have been perf o rmed to clarify the best
a p p roach to treat fibromatosis. The aim of surg e ry
in the treatment of any aggressive fibromatosis is
complete excision with tumor-negative margins. Most
series show that “more complete” excisions result in
better local contro l1 1 - 1 3. However, these lesions have
Fig 3. Follow-up MRI, post-operative showing re c u rrent tumoral tissue in the skull base cen -
tred upon the basi-sphenoid.
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data are limited, re g ression of tumors in response to
tamoxifen has been re p o rt e d1 6.
Tr a n s f o rmation of aggressive fibromatosis to malig-
nant sarcomas is exceedingly rare. Only a few cases of
t r a n s f o rmation have been re p o rted in the literature2.
In conclusion, fibromatosis is a histologically
benign fibroblastic proliferative lesion that is local-
ly aggressive but does not metastasize. An intracra-
nial location is extremely rare. Treatment consists of
an adequate three-dimensional imaging evaluation,
complete resection is often impossible to achieve be-
cause of the infiltrative nature of the lesion. Post-
operative radiotherapy, chemotherapy, and re c e n t-
l y, hormonal adjuvant therapy have been used in an
effort to control local recurrence.
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no capsule and so they tend to infiltrate surro u n d-
ing tissues micro s c o p i c a l l y, becoming complete exci-
sion often impossible. This is especially true in the
head and neck and particularly the cranial base,
w h e re the density of vascular and neural stru c t u re s
often prevents complete excision. In our case, a total
excision with negative margins was impossible be-
cause of the extensive cranial base involvement with
massive bone destruction and infiltration. The lesion
was also very difficult to remove, being adherent to
and infiltrating surrounding structures.
In the series from Perez-Cruet et al.2, four of the
five initial surgical pro c e d u res for skull base fibro m a-
tosis had gross macroscopic resections, but marg i n s
w e re involved in all cases. Two of the four patients
experienced re c u rrences and the patient who under-
went grossly incomplete initial resection had multi-
ple re c u rrences. West recommend nonsurgical tre a t-
ment for aggressive fibromatosis, particularly in situa-
tions in which a wide field resection would result in
unacceptable morbidity14.
Several series have re p o rted that radiotherapy can
i m p rove the local control of fibro m a t o s i s1 , 2, and has
been used in extracranial lesions to control marg i n a l
and incomplete resections and to treat re c u rrent dis-
ease. Radiotherapy was not used on gross tumour
masses in the patients re p o rted by Pere z - C ruet et al.2,
so re g ression could not be assessed. Of the three pa-
tients treated with postoperative radiotherapy, two
remained free of re c u rrent disease. Chemotherapy
has also been used successfully to treat fibro m a t o s i s1 4,
primarily in the pediatric population. Goepfert et al.1 5
re p o rted six patients with desmoid fibromatosis or
f i b ro s a rcoma grade 1 desmoid type. The two chemo-
therapeutic regimens administered systemically were :
1. adriamycin and dacarbazene; 2. vincristine, dactin-
omycin and cyclophosphamide. Four patients re s p o n d-
ed part i a l l y, whereas two patients demonstrated com-
plete re g ression of their tumors. Because tumor cell
e x p ression of estrogen receptors has been demon-
strated in aggressive fibromatosis, hormonal therapy
with tamoxifen has been attempted. Although the
